The Appendix Cancer PMP Research Foundation (ACPMP) proudly announces the publication of a landmark article in Nature Reviews Cancer entitled “Defining a 'cells to society' research framework for appendiceal tumors.” This pivotal Expert Recommendation, officially published online on February 20, is the direct result of the Appendix Cancer PMP Research Foundation Scientific Think Tank—an innovative, multidisciplinary gathering designed to advance...

Thanks to the generosity of our donors, ACPMP is proud to fund two 2025 Society of Surgical Oncology (SSO) research grants focused solely on appendix cancer and PMP—including a significant new award in memory of our founder. SSO advances cancer research by providing research funding through its competitive Clinical Investigator and Young Investigator Awards programs. Introducing the Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma...

February is recognized as National Cancer Prevention Month, an important time to discuss ways to reduce cancer risks and promote overall health. Yet, for appendix cancer—including Pseudomyxoma Peritonei (PMP)—no specific causes have been definitively identified. Below, we’ll explore what is currently known about appendix cancer, share general cancer prevention strategies recommended by leading authorities, and highlight the importance of ongoing...

$50,000 Grant Awarded to Dr. Andrew Lowy for Groundbreaking Research on Mucinous Appendix Cancer SPRINGFIELD, PA, UNITED STATES, December 19, 2024 /EINPresswire.com/ -- The Appendix Cancer PMP Research Foundation (ACPMP) is pleased to announce a historic achievement: the launch of a second Catalyst Research Grant cycle within the same year, culminating in the funding of a third $50,000 research grant in 2024....

Giving Tuesday, celebrated annually on the Tuesday after Thanksgiving, is a global day of giving fueled by the power of collaboration and community. It’s a day when people come together to support causes close to their hearts and make a tangible impact. This year, the Appendix Cancer PMP Research Foundation joined the movement once again, and thanks to your generosity,...

SPRINGFIELD, PA, UNITED STATES, October 17, 2024 / -- The 2024 Annual Virtual Appendix Cancer Multi-Regional Symposium, presented by the Appendix Cancer Pseudomyxoma Peritonei Research Foundation (ACPMP), will be held on November 1, 2024. Co-sponsored by leading medical institutions including Yale Cancer Center, Atrium Health Levine Cancer, and University of Utah Huntsman Cancer Institute, this symposium will bring together top scientists,...

Researchers at UC San Diego have found that palbociclib, a breast cancer drug, shows promise for treating a rare form of appendix cancer called peritoneal mucinous carcinomatosis (PMC). Dr. Andrew Lowy, co-senior author and ACPMP Medical Advisory Board Member, says, "Finding that a breast cancer drug is successful in treating a subset of appendix cancer — where treatment options are...

Thank You for a Remarkable Appendix Cancer Awareness Month! As we wrap up Appendix Cancer Awareness Month, we want to take a moment to express our heartfelt gratitude to our volunteers, supporters, and community. This month has been a resounding success, and it wouldn't have been possible without their unwavering support and dedication. To our volunteers - your tireless efforts,...

We are thrilled to announce that ACPMP is funding a significant new $100,000 grant this year: The Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award! Thanks to all of our supporters and their donations, ACPMP is pleased to be able to fund this Society of Surgical Oncology (SSO) award focused solely on appendix cancer and PMP. Named...

Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation Announces the Lighting of Landmarks to raise awareness for Appendix Cancer Awareness Month. BOSTON, MA, USA, July 31, 2024 /EINPresswire.com/ -- ACPMP is proud to announce the launch of Appendiceal Cancer Awareness Month this August. In an effort to bring attention to this rare but critical disease, iconic buildings and landmarks across the...